Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Raderer

Showing results (61-70 of 172) with videos related to

Pageof 18
Sort By:
International Journal of Oncology|October 28, 1999
Resveratrol pretreatment desensitizes AHTO-7 human osteoblasts to growth stimulation in response to carcinoma cell supernatantsE Ulsperger, G Hamilton, M Raderer, et al.
Oncology|June 16, 2001
Treatment of advanced hepatocellular carcinoma with biweekly high-dose gemcitabineH Ulrich-Pur, G V Kornek, W Fiebiger, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Amonafide as first-line chemotherapy for metastatic breast cancerG Kornek, M Raderer, D Depisch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 3, 2001
Subcutaneous administration of amifostine: a promising therapeutic option in patients with oxaliplatin-related peripheral sensitive neuropathyM Penz, G V Kornek, M Raderer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 6, 2007
Pathology and clinical course of MALT lymphoma with plasmacytic differentiationS Wöhrer, M Troch, B Streubel, et al.
British Journal of Cancer|July 14, 1998
123I-labelled vasoactive intestinal peptide receptor scintigraphy in patients with colorectal cancerM Raderer, A Kurtaran, M Hejna, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 16, 2002
Intermittent weekly high-dose capecitabine in combination with oxaliplatin: a phase I/II study in first-line treatment of patients with advanced colorectal cancerW Scheithauer, G V Kornek, M Raderer, et al.
European Journal of Cancer (Oxford, England : 1990)|December 1, 1996
A phase I/II trial of epirubicin and high dose tamoxifen as a potential modulator of multidrug resistance in advanced hepatocellular carcinomaM Raderer, J Pidlich, C Müller, et al.
Journal of Neuro-Oncology|February 24, 2001
Evidence of therapeutic efficacy of CCNU in recurrent choroid plexus papillomaJ Valencak, W Dietrich, M Raderer, et al.
British Journal of Cancer|September 22, 1998
Reinduction therapy with the same cytostatic regimen in patients with advanced colorectal cancerM Hejna, G V Kornek, M Raderer, et al.
Pageof 18

Showing results (61-70 of 172) with videos related to

Sort By:
Pageof 18
International Journal of Oncology|October 28, 1999
Resveratrol pretreatment desensitizes AHTO-7 human osteoblasts to growth stimulation in response to carcinoma cell supernatantsE Ulsperger, G Hamilton, M Raderer, et al.
Oncology|June 16, 2001
Treatment of advanced hepatocellular carcinoma with biweekly high-dose gemcitabineH Ulrich-Pur, G V Kornek, W Fiebiger, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Amonafide as first-line chemotherapy for metastatic breast cancerG Kornek, M Raderer, D Depisch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 3, 2001
Subcutaneous administration of amifostine: a promising therapeutic option in patients with oxaliplatin-related peripheral sensitive neuropathyM Penz, G V Kornek, M Raderer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 6, 2007
Pathology and clinical course of MALT lymphoma with plasmacytic differentiationS Wöhrer, M Troch, B Streubel, et al.
British Journal of Cancer|July 14, 1998
123I-labelled vasoactive intestinal peptide receptor scintigraphy in patients with colorectal cancerM Raderer, A Kurtaran, M Hejna, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 16, 2002
Intermittent weekly high-dose capecitabine in combination with oxaliplatin: a phase I/II study in first-line treatment of patients with advanced colorectal cancerW Scheithauer, G V Kornek, M Raderer, et al.
European Journal of Cancer (Oxford, England : 1990)|December 1, 1996
A phase I/II trial of epirubicin and high dose tamoxifen as a potential modulator of multidrug resistance in advanced hepatocellular carcinomaM Raderer, J Pidlich, C Müller, et al.
Journal of Neuro-Oncology|February 24, 2001
Evidence of therapeutic efficacy of CCNU in recurrent choroid plexus papillomaJ Valencak, W Dietrich, M Raderer, et al.
British Journal of Cancer|September 22, 1998
Reinduction therapy with the same cytostatic regimen in patients with advanced colorectal cancerM Hejna, G V Kornek, M Raderer, et al.
Pageof 18